top of page
METAGATEWAY BANNER.jpg
The Evolving Role of Semaglutide in Diabetes, Obesity & MASH

Date:

9 October 2026

International Faculty

Dr. Aman Rajpal, MD, FACE, Dipl. of ABOM

Indian Expert

Dr. Ganapathi Bantwal, MD, DM (Endo), DNB (Endo), MNAMS

Summary

The session highlighted the interconnected relationship between type 2 diabetes, obesity and MASH, emphasising comprehensive metabolic management beyond glycemic control. Semaglutide offers benefits in glycemic control,…

GLP-1 RA Demystified: Translating Evidence into Daily Practice

Date:

22 May 2026

International Faculty

Dr. Robert F. Kushner, MD

Indian Expert

Dr. Anil Bhansali, MD (Medicine), DM (Endocrinology)

Summary

The session focused on evolving obesity management with GLP-1 receptor agonists, emphasizing that pharmacotherapy should be initiated early alongside lifestyle modification rather than after treatment failure.…

Managing Diabetes with the Heart in Mind: A New Standard of Care with the Advent of GLP-1 Therapy

Date:

21 November 2025

International Faculty

Dr. Jonathan, MD

Indian Expert

Dr. Girish Parmar, DNB (Internal Medicine), DNB (Endocrinology)

Summary

This session highlights that diabetes care is entering a new era that is no longer glucosecentric, demanding that cardiovascular protection must take a front seat as…

Transforming Obesity and Diabetes Care: Maximizing the Impact of GLP-1 Therapy

Date:

19 September 2025

International Faculty

Dr. Marc Cornier, MD

Indian Expert

Dr. Monashis Sahu MD, DM (Endocrinology), FACE (USA)

Summary

The session featured Dr. Marc Cornier, a leading expert in endocrinology and obesity, focusing on the intersection of obesity and diabetes care and the evolving therapeutic…

bottom of page